International trade · 21/11/2025Updated: 10/17/2026 · 1 min read
U.S. International Trade Commission Seeks Comments on Antibody Drug Conjugates Complaint
Summary
The U.S. International Trade Commission has received a complaint about Certain Antibody Drug Conjugates and Components Thereof and Products Containing the Same and is now soliciting public comments on any public interest issues raised by the complaint.
Original source language: Federal Register — International Trade CommissionOpen original release →